Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
Tesla Is An AI Company That The Market Won’t Reward For Now
April 24, 2024
Amazon: The Margin Train Is Gaining Speed
April 24, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
IDXX Stock News and Mentions of IDEXX Laboratories, Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where IDEXX Laboratories Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of IDEXX Laboratories, Inc. (IDXX).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the IDEXX Laboratories stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of IDEXX Laboratories, Inc. (IDXX)
April 26, 2024 (21:30) / "Benzinga" (by Benzinga Insights)
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 5 years by 5.0% on an annualized basis producing an average annual return of 16.57%. Currently, IDEXX Laboratories has a market capitalization of $41.47 billion.
In Article Trend: Somewhat-Bullish
April 26, 2024 (17:19) / "Zacks Commentary" (by Zacks Equity Research)
Philips ( PHG ) Receives FDA Warning Letter Regarding CT Systems
Philips (PHG) receives a warning letter from the FDA in respect of a manufacturing plant in China regarding faults in the manufacturing of CT systems.
In Article Trend: Neutral
April 26, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Seeking Clues to Idexx ( IDXX ) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
In Article Trend: Neutral
April 25, 2024 (18:40) / "Benzinga" (by Zacks)
West Pharmaceutical Q1 Earnings Beat, HVP Sales Weak - Becton Dickinson ( NYSE:BDX ) , Ecolab ( NYSE:ECL )
West Pharmaceutical Services, Inc. WST reported first-quarter 2024 adjusted earnings per share EPS of $1.56, which beat the Zacks Consensus Estimate by 20.9%. The bottom line, however, was down 21.2% year over year. The adjustments include expenses related to the amortization of ...
In Article Trend: Neutral
April 25, 2024 (16:50) / "Zacks Commentary" (by Zacks Equity Research)
Revvity's ( RVTY ) New Launch to Boost Tuberculosis Testing
Revvity's (RVTY) latest offering is likely to provide a new and improved workflow to lower hands-on time and enable increased lab productivity.
In Article Trend: Somewhat-Bullish
April 25, 2024 (16:44) / "Zacks Commentary" (by Zacks Equity Research)
CONMED ( CNMD ) Q1 Earnings & Revenues Surpass Estimates
CONMED's (CNMD) adjusted first-quarter earnings and revenues beat estimates on the back of strong U.S. and International markets as well as supply-chain improvement.
In Article Trend: Somewhat-Bullish
April 25, 2024 (16:37) / "Zacks Commentary" (by Zacks Equity Research)
Veeva's ( VEEV ) AI Partner Program to Develop GenAI Solutions
Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.
In Article Trend: Somewhat-Bullish
April 25, 2024 (14:31) / "Zacks Commentary" (by Zacks Equity Research)
West Pharmaceutical ( WST ) Q1 Earnings Beat, HVP Sales Weak
West Pharmaceutical's (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.
In Article Trend: Neutral
April 25, 2024 (13:15) / "Zacks Commentary" (by Zacks Equity Research)
Integer ( ITGR ) Q1 Earnings and Revenues Top Estimates
Integer (ITGR) delivered earnings and revenue surprises of 1.79% and 0.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
In Article Trend: Somewhat-Bullish
April 24, 2024 (15:43) / "Zacks Commentary" (by Zacks Equity Research)
Penumbra's ( PEN ) New Launch to Enhance Blood Clot Removal
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
In Article Trend: Somewhat-Bullish
April 23, 2024 (17:42) / "Zacks Commentary" (by Zacks Equity Research)
Reasons Why You Should Retain HealthEquity ( HQY ) Stock for Now
HealthEquity's (HQY) sustained strength in HSAs raises optimism about the stock.
In Article Trend: Somewhat-Bullish
April 23, 2024 (17:38) / "Zacks Commentary" (by Zacks Equity Research)
GE HealthCare's ( GEHC ) New Tie-Up to Boost Patient Outcomes
GE HealthCare's (GEHC) latest partnership is likely to benefit global healthcare systems by enhancing Elekta's RT offerings with its MIM Software medical imaging management solutions.
In Article Trend: Neutral
April 19, 2024 (11:56) / "Zacks Commentary" (by Zacks Equity Research)
What Lies Ahead of IDEXX Laboratories ( IDXX ) in Q1 Earnings?
IDEXX Laboratories' (IDXX) first-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
In Article Trend: Bullish
April 18, 2024 (15:40) / "Zacks Commentary" (by Zacks Equity Research)
TMO vs. IDXX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Thermo Fisher Scientific ( TMO Quick QuoteTMO - ) or Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two stocks offers value investors a better bang for their buck right now?
In Article Trend: Bullish
April 16, 2024 (19:00) / "Benzinga" (by Benzinga Insights)
$1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 10 years by 13.2% on an annualized basis producing an average annual return of 23.57%. Currently, IDEXX Laboratories has a market capitalization of $40.86 billion.
In Article Trend: Somewhat-Bullish
April 9, 2024 (22:00) / "Zacks Commentary" (by Zacks Equity Research)
Idexx Laboratories ( IDXX ) Beats Stock Market Upswing: What Investors Need to Know
Idexx Laboratories (IDXX) concluded the recent trading session at $519.81, signifying a +0.99% move from its prior day's close.
In Article Trend: Somewhat-Bullish
April 9, 2024 (18:13) / "Zacks Commentary" (by Zacks Equity Research)
Elevance Health ( ELV ) Brand Inks Deal to Better Serve Georgia
Elevance Health's (ELV) brand, Anthem Blue Cross and Blue Shield, collaborates to make the benefits of Piedmont's healthcare network available to its members across specific Georgia regions.
In Article Trend: Somewhat-Bullish
April 9, 2024 (16:00) / "Zacks Commentary" (by Zacks Equity Research)
All You Need to Know About Idexx ( IDXX ) Rating Upgrade to Buy
Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
In Article Trend: Somewhat-Bullish
April 5, 2024 (16:10) / "Zacks Commentary" (by Zacks Equity Research)
Will Idexx ( IDXX ) Beat Estimates Again in Its Next Earnings Report?
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
In Article Trend: Somewhat-Bullish
April 3, 2024 (12:50) / "Zacks Commentary" (by Zacks Equity Research)
How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
In Article Trend: Bullish
April 2, 2024 (12:31) / "Zacks Commentary" (by Zacks Equity Research)
Here's Why You Should Invest in IDEXX ( IDXX ) Stock Right Now
The strength of the CAG Diagnostics business buoys optimism for IDEXX (IDXX).
In Article Trend: Somewhat-Bullish
April 1, 2024 (12:45) / "Benzinga" (by Vandana Singh)
Investor Activism: Elanco Animal Health Settles with Ancora, Adds New Board Members - Elanco Animal Health ( NYSE:ELAN )
Elanco Animal Health Inc ELAN has reached a settlement with Ancora, enabling it to sidestep a potential proxy fight with the activist investor, expanding the board to 14 members. Ancora's nominees, Craig Wallace and Kathy Turner, are on its board while retaining its Chief Executive Officer, Jeff ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (10:30) / "Benzinga" (by PRNewswire)
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors - Elanco Animal Health ( NYSE:ELAN )
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee GREENFIELD, Ind., April 1, 2024 /PRNewswire/ -- Elanco Animal Health Incorporated ELAN today announced that it has appointed two new independent directors, Kathy Turner and Craig Wallace, to its Board of Directors ( ...
In Article Trend: Somewhat-Bullish
April 1, 2024 (10:30) / "PR Newswire" (by Elanco Animal Health)
Elanco Appoints Two Animal Health Industry Executives, Kathy Turner and Craig Wallace, to its Board of Directors
New Directors Join the Board's Renamed Finance, Strategy and Oversight Committee
In Article Trend: Somewhat-Bullish
March 27, 2024 (18:30) / "Benzinga" (by Benzinga Insights)
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 20 years by 3.81% on an annualized basis producing an average annual return of 11.64%. Currently, IDEXX Laboratories has a market capitalization of $44.59 billion.
In Article Trend: Somewhat-Bullish
March 11, 2024 (17:00) / "Benzinga" (by Benzinga Insights)
$100 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories IDXX has outperformed the market over the past 5 years by 7.8% on an annualized basis producing an average annual return of 20.48%. Currently, IDEXX Laboratories has a market capitalization of $46.65 billion.
In Article Trend: Somewhat-Bullish
March 6, 2024 (16:30) / "Zacks Commentary" (by Zacks Equity Research)
Idexx ( IDXX ) Down 1.5% Since Last Earnings Report: Can It Rebound?
Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
In Article Trend: Somewhat-Bullish
February 29, 2024 (18:08) / "PR Newswire" (by Elanco Animal Health)
Elanco Animal Health is Executing on Plan to Deliver for Shareholders
Ancora Nominates Director Candidates Despite Elanco's Meaningful Operational Progress and Good Faith Engagement with the Investor
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website